Stammdaten
Rapport Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entdeckung und Entwicklung von transformativen Kleine-Molekül-Arzneimitteln für Patienten mit Erkrankungen des zentralen Nervensystems (ZNS) konzentriert. Sein Leitproduktkandidat ist Rezeptor-assoziiertes Protein (RAP)-219, ein in der Prüfung befindliches Kleine-Molekül, das entwickelt wurde, um TARP-y8-haltiges AMPARs mit Pikomolar-Affinität zur Behandlung von fokaler Epilepsie und anderen ZNS-Erkrankungen, einschließlich peripherer neuropathischer Schmerzen und bipolarer Störung, zu hemmen. Das Unternehmen entwickelt auch RAP-199, ein TARP-y8-zielgerichtetes Molekül mit differenzierten chemischen und pharmakokinetischen Eigenschaften; sowie nikotinische Acetylcholin-Rezeptor-Programme (nAChR), wie a6 nAChR zur Behandlung chronischer Schmerzen und a9a10 nAChR zur Behandlung von Hörstörungen. Das Unternehmen war zuvor als Precision Neuroscience NewCo, Inc. bekannt und änderte seinen Namen im Oktober 2022 zu Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. wurde 2022 gegründet und hat seinen Sitz in Boston, Massachusetts. KI
Unternehmen & Branche
| Name | Rapport Therapeutics, Inc. |
|---|---|
| Ticker | RAPP |
| CIK | 0002012593 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Biotechnologie (Forschung) |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 75383L102 |
|---|---|
| ISIN | US75383L1026 |
| Typ | Common Stock |
| Marktkapitalisierung | 2,01 Mrd. USD |
| Beta | 0,86 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 99 HIGH STREET SUITE 2100, 02110 BOSTON, MA |
| Telefon | 857-321-8020 |
| EIN (IRS) | 88-0724208 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Emerging growth company |
Bewertung
| KBV (P/B) | 4,15 |
|---|---|
| FCF-Rendite | -4,4 % |
Qualität & Bilanz
| ROIC | -22,5 % |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2023. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|
| Bewertung | |||||
| KBV (P/B) | – | 2,12 | 2,99 | 4,27 | |
| FCF-Rendite | – | -10,4 % | -6,1 % | -4,0 % | |
| Qualität & Bilanz | |||||
| ROIC | – | -25,5 % | -22,5 % | -22,2 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
RAPP
Rapport Therapeutics, Inc.
Effektiv
Neutral
Handelsvolumen
Mittel
Insider
0,0
Keine Insider-Käufe
Institutionell
38,2
28 neu, 53 erhöht, 204,3M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 38.91 | +7.8 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 31.88 | +31.6 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 40.83 | EMA50: 39.09 | |
| MACD-Histogramm | Bärisch | 10 % | -0.045 | Bearisch | |
| RSI(14) | Neutral | 10 % | 55.5 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 59.0 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 28.2 | +DI: 23.7 / −DI: 11.1 | |
| Z-Score(60) | Neutral | 5 % | 1.48 | In Range | |
| 52W-Position | Bullisch | 5 % | 97.7 % | Hoch 42.62 / Tief 14.04 | |
| Bollinger(20,2σ) | Neutral | 5 % | 71.3 % | Upper 43.31 / Mid 40.95 / Lower 38.60 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.0970 | R²=0.55 / annualisiert +63.3 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -5.481 | 39,72 | -217.714,64 | -33,5% | |
| 2026-07-14 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.729 | 40,57 | -110.722,08 | -17,0% | |
| 2026-06-30 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -1.000 | 43,15 | -43.154,70 | -6,6% | |
| 2026-06-30 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -3.792 | 41,39 | -156.963,77 | -24,1% | |
| 2026-06-30 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -3.308 | 42,17 | -139.505,64 | -21,5% | |
| 2026-06-30 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -1.900 | 40,09 | -76.173,66 | -11,7% | |
| 2026-06-29 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -7.344 | 39,77 | -292.062,07 | -44,9% | |
| 2026-06-29 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -876 | 40,34 | -35.335,65 | -5,4% | |
| 2026-05-26 | Third Rock Ventures V, L.P. | 10% Owner | Open Market Sale | -18.572 | 40,05 | -743.752,88 | -114,4% | |
| 2026-05-11 | Third Rock Ventures V, L.P. | 10% Owner | Open Market Sale | -133.618 | 40,24 | -5.377.322,79 | -827,3% | |
| 2026-05-08 | Third Rock Ventures V, L.P. | 10% Owner | Open Market Sale | -5.018 | 40,31 | -202.255,51 | -31,1% | |
| 2026-05-07 | Third Rock Ventures V, L.P. | 10% Owner | Open Market Sale | -271.495 | 40,12 | -10.892.650,90 | -1675,9% | |
| 2026-04-17 | Third Rock Ventures V, L.P. | 10% Owner | Open Market Sale | -426.005 | 40,32 | -17.175.243,59 | -2642,5% | |
| 2026-04-17 | Yeleswaram Krishnaswamy | Officer, Chief Development Officer | Open Market Sale | -20.225 | 39,99 | -808.844,27 | -124,4% | |
| 2026-04-14 | Yeleswaram Krishnaswamy | Officer, Chief Development Officer | Open Market Sale | -10.200 | 35,08 | -357.796,62 | -55,0% | |
| 2026-04-13 | Yeleswaram Krishnaswamy | Officer, Chief Development Officer | Open Market Sale | -9.165 | 34,97 | -320.536,71 | -49,3% | |
| 2026-04-10 | Yeleswaram Krishnaswamy | Officer, Chief Development Officer | Open Market Sale | -500 | 34,98 | -17.490,00 | -2,7% | |
| 2026-04-08 | Yeleswaram Krishnaswamy | Officer, Chief Development Officer | Open Market Sale | -360 | 34,90 | -12.564,00 | -1,9% | |
| 2026-03-30 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -7.161 | 28,04 | -200.795,16 | -30,9% | |
| 2026-03-30 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -2.839 | 28,55 | -81.061,97 | -12,5% | |
| 2026-03-25 | Yeleswaram Krishnaswamy | Officer, Chief Development Officer | Open Market Sale | -10.115 | 29,99 | -303.354,92 | -46,7% | |
| 2026-03-05 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -2.014 | 28,93 | -58.265,02 | -9,0% | |
| 2026-02-18 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.281 | 29,80 | -67.969,92 | -10,5% | |
| 2026-02-18 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -3.552 | 29,05 | -103.191,28 | -15,9% | |
| 2026-02-18 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.983 | 29,04 | -86.639,15 | -13,3% | |
| 2026-02-18 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.100 | 29,80 | -62.572,65 | -9,6% | |
| 2026-02-17 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -5.400 | 28,95 | -156.328,38 | -24,1% | |
| 2026-02-17 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -2.200 | 29,59 | -65.107,68 | -10,0% | |
| 2026-02-17 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -900 | 28,02 | -25.218,99 | -3,9% | |
| 2026-01-20 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -5.833 | 26,12 | -152.333,46 | -23,4% | |
| 2026-01-20 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -5.083 | 26,11 | -132.737,46 | -20,4% | |
| 2026-01-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -8.300 | 26,83 | -222.651,65 | -34,3% | |
| 2026-01-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -200 | 27,40 | -5.480,00 | -0,8% | |
| 2025-12-31 | Yeleswaram Krishnaswamy | Officer, Chief Development Officer | Open Market Sale | -2.840 | 30,05 | -85.342,00 | -13,1% | |
| 2025-12-31 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -6.567 | 30,05 | -197.337,69 | -30,4% | |
| 2025-12-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -515 | 31,04 | -15.985,39 | -2,5% | |
| 2025-12-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.792 | 30,04 | -83.861,91 | -12,9% | |
| 2025-12-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.441 | 28,84 | -70.393,07 | -10,8% | |
| 2025-12-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.421 | 30,04 | -72.721,51 | -11,2% | |
| 2025-12-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.147 | 28,84 | -61.924,85 | -9,5% | |
| 2025-12-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -600 | 31,04 | -18.621,60 | -2,9% | |
| 2025-12-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -796 | 30,68 | -24.419,05 | -3,8% | |
| 2025-12-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -7.704 | 29,95 | -230.710,92 | -35,5% | |
| 2025-11-26 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -5.000 | 30,10 | -150.486,50 | -23,2% | |
| 2025-11-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.777 | 24,92 | -69.215,61 | -10,6% | |
| 2025-11-17 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -5.344 | 25,39 | -135.695,92 | -20,9% | |
| 2025-11-17 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -3.156 | 24,84 | -78.394,72 | -12,1% | |
| 2025-11-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -3.056 | 25,43 | -77.715,00 | -12,0% | |
| 2025-11-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.841 | 25,44 | -72.266,52 | -11,1% | |
| 2025-11-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -2.242 | 24,91 | -55.849,79 | -8,6% | |
| 2025-10-15 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -1.186 | 26,14 | -31.001,09 | -4,8% | |
| 2025-10-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -7.418 | 25,73 | -190.886,65 | -29,4% | |
| 2025-10-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -1.082 | 26,16 | -28.309,56 | -4,4% | |
| 2025-10-15 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -4.647 | 25,72 | -119.539,43 | -18,4% | |
| 2025-10-15 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -4.328 | 25,75 | -111.428,69 | -17,1% | |
| 2025-10-15 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -755 | 26,17 | -19.759,94 | -3,0% | |
| 2025-09-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -1.400 | 26,87 | -37.624,30 | -5,8% | |
| 2025-09-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -39.435 | 26,30 | -1.037.101,07 | -159,6% | |
| 2025-09-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -34.885 | 26,30 | -917.541,78 | -141,2% | |
| 2025-09-17 | Ceesay Abraham | Director, Officer, Chief Executive Officer | Open Market Sale | -700 | 27,04 | -18.930,03 | -2,9% | |
| 2025-09-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -5.098 | 23,88 | -121.761,14 | -18,7% | |
| 2025-09-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -3.402 | 24,66 | -83.887,54 | -12,9% | |
| 2025-09-12 | PAUL STEVEN M | Director | Open Market Purchase | 13.382 | 24,97 | 334.164,60 | +51,4% | |
| 2025-09-12 | PAUL STEVEN M | Director | Open Market Purchase | 28.284 | 24,50 | 692.946,69 | +106,6% | |
| 2025-09-12 | Huber Reid M | Director | Open Market Purchase | 20.400 | 24,48 | 499.373,64 | +76,8% | |
| 2025-09-11 | Young Wendy B. | Director | Open Market Purchase | 3.500 | 22,60 | 79.100,00 | +12,2% | |
| 2025-09-08 | Gault Cheryl | Officer, Chief Operating Officer | Open Market Sale | -5.000 | 38,33 | -191.650,00 | -29,5% | |
| 2025-08-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -200 | 15,79 | -3.158,00 | -0,5% | |
| 2025-08-15 | Bredt David | Officer, Chief Scientific Officer | Open Market Sale | -8.300 | 14,98 | -124.308,27 | -19,1% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| FMR LLC | 7.168.939 | 0 | 7.168.939 | 224.316.101 | Neu | +100,0% | |
| TRV GP V, LLC | 7.135.233 | 0 | 7.135.233 | 223.261.441 | Neu | +100,0% | |
| ARCH Venture Management, LLC | 3.728.738 | 0 | 3.728.738 | 116.672.212 | Neu | +100,0% | |
| Capital International Investors | 3.097.973 | 0 | 3.097.973 | 96.935.575 | Neu | +100,0% | |
| Cormorant Asset Management, LP | 2.957.521 | 0 | 2.957.521 | 92.540.832 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 2.942.251 | 0 | 2.942.251 | 92.063.034 | Neu | +100,0% | |
| BlackRock, Inc. | 2.505.955 | 0 | 2.505.955 | 78.411.332 | Neu | +100,0% | |
| Sofinnova Investments, Inc. | 1.904.408 | 0 | 1.904.408 | 59.588.926 | Neu | +100,0% | |
| JOHNSON & JOHNSON | 1.784.517 | 0 | 1.784.517 | 55.837.537 | Neu | +100,0% | |
| Polar Capital Holdings Plc | 1.642.461 | 0 | 1.642.461 | 51.392.605 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 1.547.090 | 0 | 1.547.090 | 48.408.446 | Neu | +100,0% | |
| Vestal Point Capital, LP | 1.436.229 | 0 | 1.436.229 | 44.939.605 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.325.082 | 0 | 1.325.082 | 41.461.816 | Neu | +100,0% | |
| TRV GP VI, LLC | 969.218 | 0 | 969.218 | 30.326.831 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 918.866 | 0 | 918.866 | 28.751.317 | Neu | +100,0% | |
| STATE STREET CORP | 759.552 | 0 | 759.552 | 23.766.382 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 721.622 | 0 | 721.622 | 22.583.176 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 727.843 | 0 | 727.843 | 22.082.757 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 673.923 | 0 | 673.923 | 21.087.051 | Neu | +100,0% | |
| Siren, L.L.C. | 641.469 | 0 | 641.469 | 20.071.565 | Neu | +100,0% | |
| Capital World Investors | 536.607 | 0 | 536.607 | 16.790.433 | Neu | +100,0% | |
| Sio Capital Management, LLC | 366.809 | 0 | 366.809 | 11.477.454 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 319.552 | 0 | 319.552 | 9.998.782 | Neu | +100,0% | |
| KENNEDY CAPITAL MANAGEMENT LLC | 257.431 | 0 | 257.431 | 8.055.016 | Neu | +100,0% | |
| Burkehill Global Management, LP | 250.000 | 0 | 250.000 | 7.822.500 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 239.917 | 0 | 239.917 | 7.507.003 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 237.992 | 0 | 237.992 | 7.446.769 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 224.498 | 0 | 224.498 | 7.024.543 | Neu | +100,0% | |
| Ensign Peak Advisors, Inc | 194.200 | 0 | 194.200 | 6.076.518 | Neu | +100,0% | |
| Candriam S.C.A. | 185.925 | 0 | 185.925 | 5.817.593 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 175.449 | 0 | 175.449 | 5.489.799 | Neu | +100,0% | |
| MORGAN STANLEY | 165.954 | 0 | 165.954 | 5.192.702 | Neu | +100,0% | |
| Swedbank AB | 117.400 | 113.200 | 4.200 | 4.892.058 | Aufgestockt | +3,7% | |
| UBS Group AG | 151.758 | 0 | 151.758 | 4.748.508 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 150.000 | 0 | 150.000 | 4.693.500 | Neu | +100,0% | |
| Freestone Grove Partners LP | 127.783 | 0 | 127.783 | 3.998.330 | Neu | +100,0% | |
| PRUDENTIAL FINANCIAL INC | 114.815 | 0 | 114.815 | 3.592.561 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 110.826 | 0 | 110.826 | 3.467.746 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 99.078 | 0 | 99.078 | 3.100.151 | Neu | +100,0% | |
| CITIGROUP INC | 78.799 | 0 | 78.799 | 2.465.621 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 78.231 | 0 | 78.231 | 2.447.849 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 75.359 | 0 | 75.359 | 2.357.983 | Neu | +100,0% | |
| DAFNA Capital Management LLC | 75.000 | 0 | 75.000 | 2.346.750 | Neu | +100,0% | |
| VOYA INVESTMENT MANAGEMENT LLC | 72.948 | 0 | 72.948 | 2.282.543 | Neu | +100,0% | |
| Nuveen, LLC | 71.508 | 0 | 71.508 | 2.237.485 | Neu | +100,0% | |
| Swiss National Bank | 56.500 | 0 | 56.500 | 1.767.885 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 56.292 | 0 | 56.292 | 1.761.377 | Neu | +100,0% | |
| XTX Topco Ltd | 47.903 | 0 | 47.903 | 1.498.885 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 44.672 | 0 | 44.672 | 1.397.787 | Neu | +100,0% | |
| ALPS ADVISORS INC | 38.907 | 0 | 38.907 | 1.217.400 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Swedbank AB | 117.400 | 113.200 | +3,7% | 4.892.058 | 54,87 | 100 % | 3 Q |
| Ellsworth Advisors, LLC | 24.539 | 0 | +100,0% | 979.842 | 10,99 | 0 % | 1 Q |
| Y-Intercept (Hong Kong) Ltd | 19.189 | 35.825 | -46,4% | 799.606 | 8,97 | 100 % | 2 Q |
| PSP Research LLC | 14.000 | 14.000 | 0,0% | 583.380 | 6,54 | 0 % | 3 Q |
| China Universal Asset Management Co., Ltd. | 10.812 | 12.058 | -10,3% | 450.536 | 5,05 | 100 % | 7 Q |
| CATALYST PRIVATE WEALTH, LLC | 10.000 | 10.000 | 0,0% | 416.700 | 4,67 | 0 % | 6 Q |
| Police & Firemen's Retirement System of New Jersey | 9.034 | 7.471 | +20,9% | 376.447 | 4,22 | 100 % | 7 Q |
| AlphaCentric Advisors LLC | 6.531 | 6.438 | +1,4% | 272.147 | 3,05 | 0 % | 3 Q |
| Mirae Asset Global Investments Co., Ltd. | 2.139 | 2.486 | -14,0% | 89.132 | 1,00 | 100 % | 7 Q |
| GAMMA Investing LLC | 408 | 378 | +7,9% | 17.001 | 0,19 | 100 % | 7 Q |
| SIGNATUREFD, LLC | 205 | 205 | 0,0% | 8.542 | 0,10 | 0 % | 6 Q |
| MassMutual Private Wealth & Trust, FSB | 163 | 163 | 0,0% | 6.792 | 0,08 | 100 % | 3 Q |
| EverSource Wealth Advisors, LLC | 147 | 147 | 0,0% | 6.125 | 0,07 | 100 % | 7 Q |
| Sterling Capital Management LLC | 141 | 975 | -85,5% | 5.875 | 0,07 | 0 % | 8 Q |
| TD Waterhouse Canada Inc. | 123 | 0 | +100,0% | 4.845 | 0,05 | 100 % | 1 Q |
| SBI Securities Co., Ltd. | 53 | 63 | -15,9% | 2.209 | 0,02 | 100 % | 5 Q |
| True Wealth Design, LLC | 41 | 44 | -6,8% | 1.709 | 0,02 | 0 % | 6 Q |
| Bare Financial Services, Inc | 39 | 0 | +100,0% | 1.625 | 0,02 | 100 % | 2 Q |
| Versant Capital Management, Inc | 27 | 27 | 0,0% | 1.125 | 0,01 | 100 % | 2 Q |
| IFP Advisors, Inc | 3 | 3 | 0,0% | 125 | 0,00 | 100 % | 5 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 20 | 0,2 | 9 |
| 31.03.2026 | ✓ | 145 | 54,3 | 1.652 |
| 31.12.2025 | ✓ | 139 | 52,4 | 1.537 |
| 30.09.2025 | ✓ | 121 | 47,7 | 1.362 |
| 30.06.2025 | ✓ | 80 | 38,4 | 411 |
| 31.03.2025 | ✓ | 74 | 37,4 | 348 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| ARCH Venture Management, LLC | 3.728.738 | 116.672.212 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.325.082 | 41.461.816 |
| Capital World Investors | 536.607 | 16.790.433 |
| Candriam S.C.A. | 185.925 | 5.817.593 |
| Freestone Grove Partners LP | 127.783 | 3.998.330 |
| Y-Intercept (Hong Kong) Ltd | 35.825 | 1.120.964 |
| SECTORAL ASSET MANAGEMENT INC | 25.421 | 835.005 |
| VARCOV Co. | 15.473 | 484.150 |
| Optimize Financial Inc | 14.656 | 458.586 |
| Walleye Capital LLC | 11.148 | 348.821 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| Polar Capital Holdings Plc | 1.642.461 | 637.733 | +63.5 % | 51.392.605 |
| Vestal Point Capital, LP | 1.436.229 | 326.229 | +29.4 % | 44.939.605 |
| Sio Capital Management, LLC | 366.809 | 181.544 | +98.0 % | 11.477.454 |
| DIMENSIONAL FUND ADVISORS LP | 224.498 | 141.011 | +168.9 % | 7.024.543 |
| MILLENNIUM MANAGEMENT LLC | 319.552 | 117.727 | +58.3 % | 9.998.782 |
| KENNEDY CAPITAL MANAGEMENT LLC | 257.431 | 78.694 | +44.0 % | 8.055.016 |
| BANK OF AMERICA CORP /DE/ | 110.826 | 76.273 | +220.7 % | 3.467.746 |
| BlackRock, Inc. | 2.505.955 | 74.093 | +3.0 % | 78.411.332 |
| FMR LLC | 7.168.939 | 57.074 | +0.8 % | 224.316.101 |
| STATE STREET CORP | 759.552 | 44.731 | +6.3 % | 23.766.382 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| Capital International Investors | 3.097.973 | -304.556 | -9.0 % | 96.935.575 |
| PRUDENTIAL FINANCIAL INC | 114.815 | -140.152 | -55.0 % | 3.592.561 |
| RENAISSANCE TECHNOLOGIES LLC | 9.700 | -109.114 | -91.8 % | 303.513 |
| UBS Group AG | 151.758 | -74.602 | -33.0 % | 4.748.508 |
| D. E. Shaw & Co., Inc. | 175.449 | -71.866 | -29.1 % | 5.489.799 |
| Cormorant Asset Management, LP | 2.957.521 | -70.000 | -2.3 % | 92.540.832 |
| Siren, L.L.C. | 641.469 | -67.000 | -9.5 % | 20.071.565 |
| ALLIANCEBERNSTEIN L.P. | 727.843 | -60.568 | -7.7 % | 22.082.757 |
| GOLDMAN SACHS GROUP INC | 2.942.251 | -59.628 | -2.0 % | 92.063.034 |
| MORGAN STANLEY | 165.954 | -44.377 | -21.1 % | 5.192.702 |
Zusätzlich aktuell von 96 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck | Δ-Balken |
|---|---|---|---|---|---|---|---|
| 15.05.2026 | Cormorant Asset Management, LP (+1) | Passiv (13G/A) | 6,19 % | 2.957.521 | -0,16 pp | – | |
| 17.02.2026 | Cormorant Asset Management, LP (+1) | Passiv (13G/A) | 6,35 % | 3.027.521 | -0,35 pp | – | |
| 21.01.2026 | BlackRock, Inc. | Passiv (13G) | 5,03 % | 2.397.549 | Neu | – | |
| 14.11.2025 | Cormorant Asset Management, LP (+1) | Passiv (13G/A) | 6,70 % | 3.192.521 | -1,34 pp | – | |
| 22.10.2025 | Johnson & Johnson Innovation - JJDC, Inc. (+1) | Passiv (13G/A) | 4,90 % | 1.784.517 | Neu | – | |
| 18.09.2025 | Dr. James I. Healy ("Healy") | Aktivist (13D/A) | 4,20 % | 1.947.579 | Neu | The Reporting Persons hold their securities of the Issuer for investment purposes. Depe… | |
| 18.09.2025 | Sofinnova Venture Partners XI, L.P. ("SVP XI") (+3) | Aktivist (13D/A) | 4,00 % | 1.863.327 | Neu | The Reporting Persons hold their securities of the Issuer for investment purposes. Depe… | |
| 13.02.2025 | Third Rock Ventures GP VI, L.P. (+2) | Passiv (13G) | 2,70 % | 969.218 | Neu | – | |
| 13.02.2025 | Third Rock Ventures GP V, L.P. (+2) | Passiv (13G) | 19,50 % | 7.135.233 | Neu | – | |
| 14.11.2024 | Cormorant Asset Management, LP (+1) | Passiv (13G/A) | 8,04 % | 2.940.921 | 0,00 pp | – | |
| 14.11.2024 | ARCH Venture Partners XII, L.P. (+6) | Passiv (13G) | 10,20 % | 3.728.738 | Neu | – | |
| 13.11.2024 | Capital International Investors | Passiv (13G) | 7,10 % | 2.602.529 | Neu | – | |
| 18.10.2024 | Johnson & Johnson Innovation-JJDC, Inc. (+1) | Passiv (13G) | 6,80 % | 2.498.051 | Neu | – | |
| 24.06.2024 | WSLS OFFSHORE INVESTMENTS, SLP | Passiv (13G/A) | 0,90 % | 327.060 | 0,00 pp | – | |
| 24.06.2024 | THE GOLDMAN SACHS GROUP, INC. (+1) | Passiv (13G/A) | 3,50 % | 1.285.188 | -4,00 pp | – | |
| 24.06.2024 | BROAD STREET PRINCIPAL INVESTMENTS, L.L.C. | Passiv (13G/A) | 0,70 % | 233.735 | 0,00 pp | – | |
| 24.06.2024 | WEST STREET LIFE SCIENCES I, L.P. | Passiv (13G/A) | 0,90 % | 326.566 | 0,00 pp | – | |
| 24.06.2024 | WSLS EMP OFFSHORE INVESTMENTS, L.P. | Passiv (13G/A) | 0,30 % | 89.728 | 0,00 pp | – | |
| 24.06.2024 | WSLS EMP ONSHORE INVESTMENTS, L.P. | Passiv (13G/A) | 0,70 % | 237.870 | 0,00 pp | – | |
| 21.06.2024 | THE GOLDMAN SACHS GROUP, INC. (+1) | Passiv (13G) | 7,50 % | 2.665.682 | Neu | – | |
| 21.06.2024 | WSLS EMP OFFSHORE INVESTMENTS, L.P. | Passiv (13G) | 0,30 % | 89.728 | Neu | – | |
| 21.06.2024 | WSLS OFFSHORE INVESTMENTS, SLP | Passiv (13G) | 0,90 % | 327.060 | Neu | – | |
| 21.06.2024 | WSLS EMP ONSHORE INVESTMENTS, L.P. | Passiv (13G) | 0,70 % | 237.870 | Neu | – | |
| 21.06.2024 | BROAD STREET PRINCIPAL INVESTMENTS, L.L.C. | Passiv (13G) | 0,70 % | 233.735 | Neu | – | |
| 21.06.2024 | WEST STREET LIFE SCIENCES I, L.P. | Passiv (13G) | 0,90 % | 326.566 | Neu | – | |
| 20.06.2024 | Cormorant Private Healthcare Fund IV, LP (+1) | Passiv (13G) | 0,63 % | 229.717 | Neu | – | |
| 20.06.2024 | Cormorant Private Healthcare Fund III, LP (+1) | Passiv (13G) | 1,90 % | 694.443 | Neu | – | |
| 20.06.2024 | Cormorant Global Healthcare Master Fund, LP (+1) | Passiv (13G) | 3,51 % | 1.283.673 | Neu | – | |
| 20.06.2024 | Cormorant Asset Management, LP (+1) | Passiv (13G) | 8,04 % | 2.940.283 | Neu | – | |
| 20.06.2024 | Cormorant Private Healthcare Fund V, LP (+1) | Passiv (13G) | 2,00 % | 732.450 | Neu | – | |
| 14.06.2024 | Dr. James I. Healy (“Healy”) | Aktivist (13D) | 5,50 % | 1.951.562 | Neu | – | |
| 14.06.2024 | Sofinnova Venture Partners XI, L.P. (“SVP XI”) (+3) | Aktivist (13D) | 5,30 % | 1.863.327 | Neu | – |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 20.000.000 $ | -19.857.000 $ | -0,42 $ | 497.597.000 $ | 471.512.000 $ |
| 2025-12-31 | 10-K | – | -111.483.000 $ | -2,86 $ | 512.431.000 $ | 484.653.000 $ |
| 2025-09-30 | 10-Q | – | -26.925.000 $ | -0,71 $ | 535.323.000 $ | 511.617.000 $ |
| 2025-06-30 | 10-Q | – | -26.732.000 $ | -0,75 $ | 285.495.000 $ | 263.512.000 $ |
| 2025-03-31 | 10-Q | 0 $ | -24.063.000 $ | -0,68 $ | 302.053.000 $ | 285.836.000 $ |
| 2024-12-31 | 10-K | – | -78.307.000 $ | -3,78 $ | 314.933.000 $ | 305.427.000 $ |
| 2024-09-30 | 10-Q | – | -17.537.000 $ | -0,50 $ | 331.144.000 $ | 323.114.000 $ |
| 2024-06-30 | 10-Q | – | -18.121.000 $ | -1,70 $ | 346.098.000 $ | 336.886.000 $ |
| 2024-03-31 | 10-Q | – | -22.669.000 $ | -11,07 $ | – | -39.633.000 $ |
| 2023-12-31 | 10-K | – | -34.786.000 $ | -23,10 $ | 155.423.000 $ | -25.634.000 $ |
| 2023-09-30 | 10-Q | – | -8.709.000 $ | -5,70 $ | – | -13.117.000 $ |
| 2023-06-30 | 10-Q | – | -6.411.000 $ | -4,45 $ | – | -9.433.000 $ |
| 2023-03-31 | 10-Q | – | -6.147.000 $ | – | – | -3.997.000 $ |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | 20,0 Mio. USD | -0,42 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | – | -0,71 |
| Q2 2025 | 30.06.2025 | 07.08.2025 | – | -0,75 |
| Q1 2025 | 31.03.2025 | 08.05.2025 | 0 USD | -0,68 |
| Q3 2024 | 30.09.2024 | 07.11.2024 | – | -0,50 |
| Q2 2024 | 30.06.2024 | 08.08.2024 | – | -1,70 |
| Q1 2024 | 31.03.2024 | 08.08.2024 | – | -11,07 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | – | -5,70 |
| Q2 2023 | 30.06.2023 | 08.08.2024 | – | -4,45 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | 31.03.2026 | 37 Tage | SEC » |
| 10.03.2026 | 10-K | 31.12.2025 | 69 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 11.03.2025 | 10-K | 31.12.2024 | 70 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 07.01.2026 | Kapitalerhöhung | $110,0 Mio | SEC » |
| 10.09.2025 | Kapitalerhöhung | $250,0 Mio · $26,00/Aktie | SEC » |
| 08.09.2025 | Kapitalerhöhung | $250,0 Mio | SEC » |
| 07.06.2024 | Börsengang | $136,0 Mio · $17,00/Aktie | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 23.04.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 23.04.2026 | HV-Einladung | 10.06.2026 Jahres-HV | 14.04.2026 | DEF 14A | SEC » |
| 24.04.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 24.04.2025 | HV-Einladung | 17.06.2025 Jahres-HV | 21.04.2025 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 10.06.2026 | HV-Abstimmung | 0,00 | 35 | Am 10. Juni 2026 hielt Rapport Therapeutics ihre Jahresversammlung mit 47,8 Mio. abstimmungsberechtigten Aktien ab. Die eingereichten Abstim… 🔒 | SEC |
| 07.05.2026 | Quartalszahlen | 0,15 | 55 | Rapport Therapeutics kündigte Finanzergebnisse und Business Highlights für das Q1 2026 (bis 31. März 2026) an. | SEC |
| 21.04.2026 | Sonstiges | 0,70 | 68 | Rapport Therapeutics präsentierte Phase-2a-Nachbeobachtungsergebnisse zu RAP-219 mit anhaltender Anfallsreduktion bei fokalen Anfallsstörung… 🔒 | SEC |
| 10.03.2026 | Quartalszahlen | 0,00 | 45 | Rapport Therapeutics kündigte Finanzergebnisse und Business Highlights für Q4 und Gesamtjahr 2025 an. Weitere Details im Press Release. | SEC |
| 07.01.2026 | Sonstiges | 0,40 | 50 | Rapport Therapeutics kündigte die beschleunigte Initiierung des RAP-219-Programms sowie eine Erweiterung seines Epilepsie-Portfolios an und … 🔒 | SEC |
| 07.01.2026 | Sonstiges | -0,15 | 55 | Rapport Therapeutics kündigte die Registrierung einer Aktienemission über bis zu 110 Millionen Dollar via Prospekt-Ergänzung zur S-3-Registr… 🔒 | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-26 | 36 | 38,91 | 1.401 |
| 2026-06-24 | 4.340 | 38,88 | 168.739 |
| 2026-05-29 | 6.571 | 39,49 | 259.489 |
| 2026-05-28 | 4.384 | 39,51 | 173.212 |
| 2026-05-27 | 4.378 | 39,71 | 173.850 |
| 2026-05-22 | 41.900 | 36,70 | 1.537.730 |
| 2026-05-20 | 1.047 | 34,37 | 35.985 |
| 2026-05-19 | 352 | 35,18 | 12.383 |
| 2026-05-18 | 200 | 37,07 | 7.414 |
| 2026-05-14 | 2.292 | 38,08 | 87.279 |
| 2026-05-12 | 57 | 38,43 | 2.191 |
| 2026-05-08 | 4.238 | 39,93 | 169.223 |
| 2026-05-07 | 806 | 37,06 | 29.870 |
| 2026-05-04 | 500 | 33,89 | 16.945 |
| 2026-04-22 | 16.400 | 36,95 | 605.980 |
| 2026-04-15 | 650 | 36,15 | 23.498 |
| 2026-04-08 | 58 | 33,49 | 1.942 |
| 2026-04-06 | 7.136 | 33,58 | 239.627 |
| 2026-04-02 | 282 | 31,67 | 8.931 |
| 2026-04-01 | 8.485 | 31,29 | 265.496 |
| 2026-03-31 | 2.256 | 27,69 | 62.469 |
| 2026-03-27 | 78 | 29,00 | 2.262 |
| 2026-03-25 | 352 | 28,25 | 9.944 |
| 2026-03-23 | 7 | 27,08 | 190 |
| 2026-03-17 | 128 | 27,62 | 3.535 |
| 2026-03-16 | 2.419 | 27,84 | 67.345 |
| 2026-03-13 | 12.458 | 28,67 | 357.171 |
| 2026-03-09 | 44 | 30,24 | 1.331 |
| 2026-03-04 | 5.853 | 27,85 | 163.006 |
| 2026-03-03 | 7.405 | 28,37 | 210.080 |
| 2026-02-27 | 69 | 29,50 | 2.036 |
| 2026-02-25 | 71 | 28,99 | 2.058 |
| 2026-02-24 | 3.506 | 30,12 | 105.601 |
| 2026-02-17 | 60 | 27,93 | 1.676 |
| 2026-02-06 | 39.454 | 25,55 | 1.008.050 |